Literature DB >> 517715

Respiratory effects of butorphanol and pethidine.

T Kallos, F S Caruso.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 517715     DOI: 10.1111/j.1365-2044.1979.tb06362.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


× No keyword cloud information.
  5 in total

1.  Measurement of meperidine-induced respiratory depression using a new non-invasive technique.

Authors:  E V Hersh; P J Desjardins; M Simpser; C Dadzie
Journal:  Anesth Prog       Date:  1985 Sep-Oct

Review 2.  Clinical pharmacokinetics of narcotic agonist-antagonist drugs.

Authors:  R E Bullingham; H J McQuay; R A Moore
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

Review 3.  Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain management.

Authors:  J C Gillis; P Benfield; K L Goa
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

4.  Comparison of fentanyl and butorphanol for outpatient anaesthesia.

Authors:  S K Pandit; S P Kothary; U A Pandit; M K Mathai
Journal:  Can J Anaesth       Date:  1987-03       Impact factor: 5.063

5.  Butorphanol: an opioid for day-care paediatric surgery.

Authors:  W M Splinter; H V O'Brien; L Komocar
Journal:  Can J Anaesth       Date:  1995-06       Impact factor: 5.063

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.